Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM1 | Q13255 | 4/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | OGA | O60502 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31180237 | 0.95 | GRM1 (0.35) | GRM1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL10287327 | 0.70 | ACHE (0.31) | ACHEHTR2AHTR2CHTR2B | |
| SCHEMBL31180249 | 0.69 | HTR2A (0.32) | GRM1HTR2AHTR2CHTR2B | |
| SCHEMBL10286894 | 0.69 | ALDH1A1 (0.35) | HTR2AHTR2CHTR2B | |
| SCHEMBL2407668 | 0.68 | ACHE (0.36) | ACHE | |
| SCHEMBL25257298 | 0.68 | ACHE (0.39) | GRM1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL32680184 | 0.68 | HTR2A (0.31) | HTR2AHTR2CHTR2B | |
| SCHEMBL17450949 | 0.67 | CA2 (0.42) | — | |
| SCHEMBL26628020 | 0.66 | GRM1 (0.43) | GRM1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL31180162 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4703362-A1 | COMPOUND CONTAINING OXO-PYRIDO-ALIPHATIC RING OR ALIPHATIC HETEROCYCLIC STRUCTURE, AND MEDICAL USE THEREOF | Chengdu Sibeibo Pharmaceutical Technology Co., Ltd (CN) | 2026-03-04 | — | — | EP | disclosed |
| WO-2025061141-A1 | PHARMACEUTICAL COMPOSITION HAVING IMPROVED PHARMACOKINETIC PROPERTIES | 成都思倍博医药科技有限公司 | 2025-03-27 | — | — | WO | disclosed |
| WO-2024222889-A1 | COMPOUND CONTAINING OXO-PYRIDO-ALIPHATIC RING OR ALIPHATIC HETEROCYCLIC STRUCTURE, AND MEDICAL USE THEREOF | 成都思倍博医药科技有限公司 | 2024-10-31 | — | — | WO | disclosed |